Literature DB >> 19734665

Protective effect of clove oil-supplemented fish diets on experimental Lactococcus garvieae infection in tilapia.

Pongsak Rattanachaikunsopon1, Parichat Phumkhachorn.   

Abstract

The essential oils extracted from the four herbs, cinnamon (Cinnamomum verum), clove (Syzygium aromaticum), ginger (Zingiber officinale) and holy basil (Ocimum sanctum), were investigated for their antimicrobial activity and mode of action against Lactococcus garvieae, a fish pathogenic bacteria causing lactococcosis. Of all the tested oils, clove oil had the strongest inhibitory effect and exhibited a bactericidal mode of action against the pathogenic bacterium. When an intraperitoneal infection of tilapia (Oreochromis niloticus) with L. garvieae was performed, the median lethal dose (LD(50)) was determined to be 1.78x10(2) CFU/fish. For an in vivo trial, no mortality was apparent in fish fed on the fish diets supplemented with 3% (w/w) of clove oil and with 0.5% (w/w) of oxytetracycline 5 d prior to the infection with L. garvieae. These results indicate that clove oil had a protective effect on experimental L. garvieae infection in tilapia and the potential to replace antibiotics for controlling the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734665     DOI: 10.1271/bbb.90294

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  Effects of Different Levels of Pomegranate Seed Oil on Some Blood Parameters and Disease Resistance Against Yersinia ruckeri in Rainbow Trout.

Authors:  Ümit Acar; Vincenzo Parrino; Osman Sabri Kesbiç; Giuseppe Lo Paro; Concetta Saoca; Francesco Abbate; Sevdan Yılmaz; Francesco Fazio
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

2.  A whole-cell Lactococcus garvieae autovaccine protects Nile tilapia against infection.

Authors:  Patricia Bwalya; Bernard M Hang'ombe; Amr A Gamil; Hetron M Munang'andu; Øystein Evensen; Stephen Mutoloki
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.